                               SEQUENCE LISTING

<110> BICYCLETX LIMITED
 
<120> MODIFICATION OF POLYPEPTIDES

<130> P5816PC00

<140> PCT/EP2018/060498
<141> 2018-04-24

<150> GB 1706477.5
<151> 2017-04-24

<160> 26    

<170> PatentIn version 3.5

<210> 1
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Cys Leu Asn Gly Cys Arg Asn Thr Asn Ser Gln Cys 
1               5                   10          


<210> 2
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Cys Leu Ser Cys Ala Arg His Gly Asn Gln Cys 
1               5                   10      


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Cys Gln Leu Thr Cys Leu Thr Pro Ala Arg Gln Pro Gly Cys 
1               5                   10                  


<210> 4
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Cys Gln Leu Thr Cys Leu Pro Pro Pro Arg Gln Pro Gly Cys 
1               5                   10                  


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Cys Pro Leu Met Ser Ser Val Asn Cys Thr Ala Gly Cys 
1               5                   10              


<210> 6
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Cys Gln Thr Leu Cys Asn Thr Ala Glu Asp Ile Arg Cys 
1               5                   10              


<210> 7
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Cys Arg Ala Val His Ser Leu Arg Cys Leu Thr Thr Cys 
1               5                   10              


<210> 8
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Ala Cys Leu Asn Gly Cys Arg Asn Thr Asn Ser Gln Cys Ala 
1               5                   10                  


<210> 9
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Ala Cys Leu Ser Cys Ala Arg His Gly Asn Gln Cys Ala 
1               5                   10              


<210> 10
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Ala Cys Pro Leu Met Ser Ser Val Asn Cys Thr Ala Gly Cys Ala 
1               5                   10                  15  


<210> 11
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Ala Cys Gln Leu Thr Cys Leu Thr Pro Ala Arg Gln Pro Gly Cys Ala 
1               5                   10                  15      


<210> 12
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Ala Cys Gln Leu Thr Cys Leu Pro Pro Pro Arg Gln Pro Gly Cys Ala 
1               5                   10                  15      


<210> 13
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
Ala Cys Gln Thr Leu Cys Asn Thr Ala Glu Asp Ile Arg Cys Ala 
1               5                   10                  15  


<210> 14
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Ala Cys Arg Ala Val His Ser Leu Arg Cys Leu Thr Thr Cys Ala 
1               5                   10                  15  


<210> 15
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
Cys Lys Met Glu Ser Trp Glu Cys Leu Met Leu His Pro Lys Cys 
1               5                   10                  15  


<210> 16
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 16
Cys Gln Asn Arg Phe Pro Asn Cys Pro Ile Asn Gly Phe Phe Cys 
1               5                   10                  15  


<210> 17
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
Cys Pro Tyr Ser Trp Glu Thr Cys Leu Phe Gly Asp Tyr Arg Cys 
1               5                   10                  15  


<210> 18
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Cys Tyr Asn Glu Phe Gly Cys Glu Asp Phe Tyr Asp Ile Cys 
1               5                   10                  


<210> 19
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Cys Ile Pro Asp Pro Tyr Gln Cys Val Ile Leu Arg Gln Pro Cys 
1               5                   10                  15  


<210> 20
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Cys Ala Val Cys Pro Tyr Pro Ala Gly Val Ser Cys 
1               5                   10          


<210> 21
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Cys Tyr His Cys Phe Phe Pro Asp His Asn Pro Cys 
1               5                   10          


<210> 22
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Cys Ala Tyr Cys Phe Tyr Pro Glu Met Asn Pro Cys 
1               5                   10          


<210> 23
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 23
Cys Asp Thr Arg Phe Trp Trp Cys Arg Gly Pro Thr Arg Leu Cys 
1               5                   10                  15  


<210> 24
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 24
Cys Gly Lys Pro Ile Trp Ser Cys Pro Met Thr Pro Asn Leu Cys 
1               5                   10                  15  


<210> 25
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 25
Cys Gly Tyr Ser Leu Leu Thr Cys Thr Trp Lys Glu Trp Asp Cys 
1               5                   10                  15  


<210> 26
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 26
Cys Arg Ala Ser Ala Gly Gln Cys Asn Pro Asp Pro Lys Leu Cys 
1               5                   10                  15  


